Company News

Phlow Corp., a U.S.-based public benefit corporation and contract development and manufacturing organization (CDMO),  announced that it has closed a $36 million Series B capital raise as part of its mission to protect America’s medicine cabinet. Since its launch in 2020, Phlow has been working to leverage advanced development and manufacturing processes to re-imagine the …

The Virginia Tech Corporate Research Center (VTCRC) announced that three companies have been selected to join Johnson & Johnson Innovation – JLABS (JLABS). Under a collaboration between VTCRC and Johnson & Johnson Innovation, LLC, established to support innovators in the Blacksburg-Roanoke region with the aim to accelerate emerging biotech and life science startups, the selected companies will …

Granules is ready to start shipping medications right from Prince William County. The India-based pharmaceutical maker opened up its new packaging and distribution facility just outside Manassas, promising to bring 57 new jobs to the county as part of a $12.5 million investment. Representatives for the $65 billion manufacturer said the move will strengthen the …

The Children’s National Board of Directors announced that Michelle Riley-Brown, MHA, FACHE, has been named as the new president and chief executive officer (CEO) of Children’s National Hospital. On July 1, Riley-Brown will succeed Kurt Newman, M.D. , who is retiring after 11 years as president and CEO. Riley-Brown is an accomplished executive with over …

During the past several years, industry demand for a skilled life science workforce has been surging. In Virginia, while there are currently shortages in almost all health-related professions, little is known about whether there is an adequate supply of life science workers to meet the needs of employers. Now George Mason University is working toward …

California Gov. Gavin Newsom has announced a new contract with nonprofit drugmaker Civica Rx, a move that brings the state one step closer to creating its own line of insulin to bring down the cost of the drug. Once the medicines are approved by the Food and Drug Administration, Newsom said at a press conference …

From designing battery electric spotter tractors to developing individualized neuro-oncology treatments for aggressive gliomas, the five companies accepted into RAMP’s Spring 2023 Cohort span the gamut of technology, health science and life science innovation. “We are thrilled to welcome these inspiring entrepreneurs and help them accelerate their vision,” said RAMP director Lisa Garcia. “Not only …

A new manufacturing facility has officially opened its doors in Charlottesville, VA, dedicated to the production of tagatose, a sweet plant-based material with numerous health benefits. The facility, owned and operated by Bonumose, will produce high-quality tagatose for use in a wide range of food and beverage products. Tagatose is 90% as sweet as table …

Indivior PLC  announced that it has completed the acquisition of Opiant Pharmaceuticals, Inc. (“Opiant”). The transaction strengthens Indivior’s addiction treatment and science portfolio by adding Opiant’s late-stage assets, notably OPNT003, an investigational opioid overdose treatment designed to offer an important treatment option to address the current wave of US opioid overdoses from powerful synthetic opioids, …

AMPEL BioSolutions  announced a genomic precision medicine test for chronic kidney diseases, such as Lupus Nephritis, that could save lives by predicting kidney damage before it is irreversible and providing decision support for prophylactic therapies.  Genes that drive the inflammatory pathways characteristic of different stages of kidney damage are revealed in the peer-reviewed journal Frontiers …

SRI International, an independent nonprofit research institute, has been awarded a $4.95 million contract, with options to fund up to $21 million, from the National Institute of Allergy and Infectious Diseases (NIAID) to develop drugs to increase the nation’s therapeutic arsenal against new or existing viral pathogens. The funds are part of the US government’s …

CytoRecovery, Inc., a leader in marker free technologies for the enrichment, sorting, and recovery of live cells, announced that the National Science Foundation (NSF) has approved its application to receive a Phase II SBIR Research Grant. Titled “Bioelectrical Cell Enrichment, Sorting, and Recovery with On-Chip Sample Prep and Monitoring,” the grant will provide $952,558 in …

Governor Glenn Youngkin announced that Engineered BioPharmaceuticals, Inc., a pharmaceutical engineering and manufacturing company dedicated to advancing cost effective, state-of-the-art medicine, will invest $6.1 million to expand in the City of Danville. The company will expand from its current lab space in the Dan River Business Development Center into its first standalone manufacturing facility at …

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced it has entered into an option agreement for the sale of the assets of Purnovate, Inc. (“Purnovate”), a wholly owned subsidiary of Adial, to Adenomed, LLC (“Adenomed”), a new company formed by Purnovate …

AMPEL BioSolutions announced a breakthrough in precision and personalized medicine that could revolutionize the way doctors treat chronic pain syndromes, such as fibromyalgia. Revealed in the peer-reviewed journal Lupus Science and Medicine, the paper details AMPEL’s breakthrough approach to characterize the underlying disease activity from gene expression data obtained from patient blood samples. The FibroGENE® lab …

Curate Biosciences  announced the commercial launch of its Curate® Cell Processing System. The first-of-its-kind Curate System produces better starting materials for CAR-T cancer therapies and other cell therapies. Its exceptionally gentle microfluidic process recovers about 90% of white blood cells with elimination of more than 90% of red cells and 99% of platelets from patient-sourced …

Richmond, VA (Richmond Bizsense/ January 23, 2023 – A Utah-based nonprofit pharmaceutical manufacturer is gearing up to kick off production at its new Petersburg plant about two years after breaking ground. With construction largely complete on the $140 million facility, Civica Rx expects to start making insulin there this year, Senior Vice President Allan Coukell …

  Forest, VA /The News and Advance/ – In 2011, Forest resident and former auditor Neil Jackson was diagnosed with chondrosarcoma — a type of cancer that affects the bones and joints. It is a rare cancer that accounts for about 20% of bone tumors. After undergoing life-threatening surgery and surviving, Jackson, now 73, was …

Deal Strengthens Zimmer Biomet’s Growing Sports Medicine Portfolio and Supports Continued Company Transformation WARSAW, Ind., /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it has reached a definitive agreement to acquire Embody, Inc., a privately-held medical device company focused on soft tissue healing, for $155 million at …

Americans living with diabetes are sometimes forced to pay $350 for a vial of lifesaving insulin. But a nonprofit pharmaceutical company coming to Petersburg plans to sell the medicine at no more than $30 a vial. The nonprofit, Civica Inc., is nearing completion on a 140,000-square-foot facility in the city’s southeast corner and plans to …

CHARLOTTESVILLE, Va., /PRNewswire/ — BrightSpec, Inc., a life science tools company commercializing Molecular Rotational Resonance (MRR) spectroscopy, announced today the closing of an $18.4 million Series C financing round, led by Genoa Ventures and Arboretum Ventures. The round includes participation from existing investors including Medvest Capital, Felton Group LLC, and the UVA Seed Fund.  Jenny Rooke, Ph.D., …

Phlow Corp. and U.S. Pharmacopeia Announce the Opening of Laboratories at the Advanced Pharmaceutical Development Center in Richmond, Virginia Richmond, VA., – Phlow Corp., a U.S.-based public benefit corporation and contract development and manufacturing organization (CDMO), and the U.S. Pharmacopeia (USP), announced the opening of laboratories co-located at the Advanced Pharmaceutical Development Center at Virginia …

Activation Capital, an innovation ecosystem development organization, announced that it has appointed Kipton Currier as its Vice President of Operations. The new role comes as the organization clarifies its strategic direction, begins raising growth capital, and adopts a fresh operational approach to its mission. Currier will help build infrastructure across multiple organizational areas, including people, …

Danville’s investment might mean a CytoRecovery presence in Danville, such as office operations or an internship at Danville Community College. CytoRecovery’s cell sorting could improve understanding of disease and development of drugs. CytoRecovery, an early-stage company that invented and patented less invasive cell sorting, will be able to bring its cell research platform to market …